USPTO To Host Virtual Panel Discussion On The Duty Of Disclosure And Duty Of Reasonable Inquiry
By Godson Umejiego, Bureau Chief, The Americas
The United States Patent and Trademark Office (USPTO) on Thursday, February 23, from 3-4 p.m. ET, will hold a virtual panel discussion on the duty of disclosure and duty of reasonable inquiry.
Last July, the USPTO issued a Federal Register notice clarifying these duties, including as to materials or statements material to patentability, or statements made to the USPTO that are inconsistent with statements submitted to the Food & Drug Administration (FDA) and other government agencies.
The panel discussion will be moderated by a patent practitioner, and the panelists will discuss and answer frequently asked questions that the USPTO has received from stakeholders. Send questions in advance to USPTO-FDAcollaboration@uspto.gov.
